Intellia Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARK INVESTMENT MANAGEMENT LLC | 10/31/2024 | 12.26 M | $251.85 M | 5.69% | 12.13% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 9.77 M | $200.83 M | 100.00% | 9.68% |
| VANGUARD GROUP INC | 11/13/2024 | 9.63 M | $197.85 M | 5.80% | 9.53% |
| STATE STREET CORP | 11/14/2024 | 5.14 M | $105.70 M | 17.90% | 5.09% |
| DEEP TRACK CAPITAL, LP | 11/14/2024 | 4.95 M | $101.72 M | 3.13% | 4.90% |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 11/05/2024 | 3.15 M | $64.72 M | -3.32% | 3.12% |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 11/07/2024 | 3.15 M | $64.67 M | -3.35% | 3.12% |
| MORGAN STANLEY | 11/14/2024 | 2.58 M | $52.94 M | 10.19% | 2.55% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 2.34 M | $48.16 M | 2.15% | 2.32% |
| FMR LLC | 11/13/2024 | 2.34 M | $48.08 M | 4.99% | 2.32% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 2.19 M | $45.08 M | 23.05% | 2.17% |
| CONTRARIUS INVESTMENT MANAGEMENT LTD | 11/08/2024 | 2.05 M | $42.07 M | 6.88% | 2.03% |
| CASDIN CAPITAL, LLC | 11/14/2024 | 2.00 M | $41.10 M | 0.00% | 1.98% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 1.45 M | $29.74 M | 9.26% | 1.43% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/12/2024 | 1.39 M | $28.67 M | 87.48% | 1.38% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 11/13/2024 | 1.08 M | $22.11 M | 4.44% | 1.07% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 1.03 M | $21.26 M | -18.33% | 1.02% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 1.03 M | $21.12 M | 33.47% | 1.02% |
| CITADEL ADVISORS LLC | 11/14/2024 | 989,439 | $20.33 M | 29.73% | 0.98% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 980,380 | $20.15 M | 18.22% | 0.97% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 827,545 | $17.01 M | 4.77% | 0.82% |
| CHEVY CHASE TRUST HOLDINGS, LLC | 11/14/2024 | 811,033 | $16.67 M | -22.21% | 0.80% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2024 | 749,861 | $15.41 M | 115.80% | 0.74% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 716,191 | $14.72 M | 10.57% | 0.71% |
| JPMORGAN CHASE & CO | 12/26/2024 | 649,054 | $13.34 M | -3.00% | 0.64% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 644,763 | $13.25 M | -17.53% | 0.64% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 582,532 | $11.97 M | -53.21% | 0.58% |
| DISCOVERY VALUE FUND | 11/14/2024 | 561,561 | $11.54 M | 0.00% | 0.56% |
| WOODLINE PARTNERS LP | 11/14/2024 | 481,752 | $9.90 M | 100.00% | 0.48% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 467,243 | $9.60 M | 3.27% | 0.46% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 438,436 | $9.01 M | 32.65% | 0.43% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 417,051 | $8.57 M | 89.02% | 0.41% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 393,100 | $8.08 M | -0.23% | 0.39% |
| CUTTER CAPITAL MANAGEMENT, LP | 11/14/2024 | 390,622 | $8.03 M | 100.00% | 0.39% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 365,867 | $7.52 M | -57.73% | 0.36% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 11/13/2024 | 335,000 | $6.88 M | 21.82% | 0.33% |
| VESTMARK ADVISORY SOLUTIONS, INC. | 11/14/2024 | 328,246 | $6.75 M | -7.62% | 0.33% |
| BARCLAYS PLC | 11/19/2024 | 292,795 | $6.02 M | 43.97% | 0.29% |
| SPHERA FUNDS MANAGEMENT LTD. | 11/14/2024 | 291,080 | $5.98 M | 108.78% | 0.29% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 288,344 | $5.93 M | -20.85% | 0.29% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 283,534 | $5.83 M | 31.93% | 0.28% |
| TEMASEK HOLDINGS (PRIVATE) LTD | 11/14/2024 | 279,693 | $5.75 M | 0.00% | 0.28% |
| UBS GROUP AG | 11/14/2024 | 278,432 | $5.72 M | 8.95% | 0.28% |
| BIOIMPACT CAPITAL LLC | 11/13/2024 | 267,557 | $5.50 M | -39.67% | 0.26% |
| RAFFERTY ASSET MANAGEMENT, LLC | 11/13/2024 | 255,548 | $5.25 M | 13.47% | 0.25% |
| JANE STREET GROUP, LLC | 11/15/2024 | 236,127 | $4.85 M | -3.79% | 0.23% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 230,301 | $4.73 M | 204.33% | 0.23% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 11/14/2024 | 211,367 | $4.35 M | -9.99% | 0.21% |
| CAPITAL ADVISORS INC/OK | 10/28/2024 | 203,775 | $4.19 M | -34.49% | 0.20% |
| WELLS FARGO & COMPANY/MN | 11/13/2024 | 200,820 | $4.13 M | -0.42% | 0.20% |
Intellia Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 377 institutional investors and hedge funds held shares of Intellia Therapeutics, Inc.. The most heavily invested institutionals were:
SALEM INVESTMENT COUNSELORS INC: 0
Global Wealth Strategies & Associates: 0
ARK Investment Management LLC: 12.26 M
BlackRock Funding, Inc. /DE: 9.77 M
VANGUARD GROUP INC: 9.63 M
STATE STREET CORP: 5.14 M
92.23% of Intellia Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 103.28 M shares in the last 24 months. This purchase volume represents approximately $1.01 B in transactions.